"The Guardian"Trump customs duties on medicines that confuse the European market and exacerbate the concerns of the drug industry
The Guardian newspaper revealed that the announcement of US President Donald Trump to impose 100% customs duties on medicines from companies whose headquarters are located in the United States raised a new state of uncertainty across Europe and anxiety between manufacturers.
& nbsp; From the fact that the 15% customs tariff agreed in July will apply to European drugs exported to the United States. He promised it since last May 8, and it may be exposed to any new customs duties. To clarify Trump’s intentions, confirming her position that customs duties on medicines may increase costs, supply chains, and prevent patients from obtaining life -saving treatments. & quot; We know that this will be concerned with the industry, and for this reason we were actively cooperating with the United States and we will continue to do this in the coming days & quot;
and continued: & quot; that sectors such as the pharmaceutical industry are extremely important to our economy; So we will continue to pressure the United States to achieve results that reflect the strength of our relationship and provide real benefits for the United Kingdom industry. United. Switzerland, was founded in 1896. Roche and Nuvarts are the two largest pharmaceutical companies in Switzerland, and they enjoy major production operations in the United States. Pharmaceutical product imports or patents from October 1, unless a specific pharmaceutical company builds a manufacturing factory in the United States.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and
